Zepp Health Corporation reported its financial results for the first quarter of 2025, revealing a revenue of $38.5 million, which marks a 3.6% decline from the first quarter of 2024. This decrease was primarily attributed to a $5.0 million reduction in the sales of Xiaomi wearable products. However, the sales of Amazfit-branded products showed a positive growth trend with a 10.2% increase year over year. The company experienced a net loss of $19.7 million for the first quarter of 2025, compared to a net loss of $14.8 million in the corresponding period of 2024. The adjusted net loss, which excludes specific non-GAAP adjustments, stood at $18.1 million, a rise from the adjusted net loss of $13.6 million in the first quarter of 2024. Looking ahead, Zepp Health projects second-quarter revenues to range between $50 million and $55 million, indicating an anticipated growth of 23% to 35% compared to the second quarter of 2024. The company also highlighted a significant shift in its debt structure, with long-term borrowings now comprising about 70% of the total debt, following the retirement of $67.8 million of debt since early 2023 and an additional $11.5 million repaid in the first quarter of 2025. The ongoing share-repurchase program reflects confidence in the company's future outlook.